News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Proteomics International Laboratories.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Mach7 lands biggest customer in history, share prices surges 20pc
Experts
After scaring everyone in 2022 it looks like ASX health stocks will have a pulse in 2023
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall this week and in need of a good rest after a tough 2022
News
Market Highlights: Stocks, Bitcoin, oil jump as inflation cools, and 5 ASX small caps to watch today
Health & Biotech
ScoPo’s Powerplays: ASX healthcare sector Christmas rally runs out of puff
Health & Biotech
ASX Health Stocks: Patent updates from Cynata and Proteomics; Ramsay sees good times ahead
News
Market Highlights: An everything rally on Wall St as inflation peaks, and 5 ASX small caps to watch on Friday
Experts
THE SUNDAY ROAST: The ASX small caps that lit a fire under Stockhead’s experts this week.
Experts
MoneyTalks: Two reasons why today’s Aussie biotech sector is like the ’90s scramble for beachside property
Health & Biotech
ASX Biotech Stocks: Fitbit wants to sell your data to doctors and Wellnex eyes OTC medicinal cannabis product
Health & Biotech
ASX Health Stocks: Mesoblast raise signals potential comeback for biotechs
News
Rise and Shine: Everything you need to know before the ASX Opens
News
Market highlights and 5 ASX small caps to watch on Monday
News
Market highlights and 5 ASX small caps to watch on Monday
Health & Biotech
Check Up: Samsung and Big Pharma give big thumbs up to biotech sector
Health & Biotech
ASX Health Stocks: ResApp’s COVID-conscious smartphone tool fails new test, shares crash 30pc
News